Oncology society’s data-analytics subsidiary growing fast

A year and a half after the American Society of Clinical Oncology (ASCO) and software partner SAP announced their CancerLinQ initiative to achieve better cancer care through big data, some 58 practices representing 1,000 providers around the country have signed on and are sharing insights from around 750,000 patient records.

According to an ASCO press release sent from the association’s just-concluded annual meeting in Chicago, the society also is now closely collaborating with Cancer Informatics for Cancer Centers (CI4CC), an academically focused nonprofit with a mission similar to CancerLinQ’s.

The two groups say they plan to launch joint initiatives to “facilitate cross-participation in a variety of avenues, including key forums, programmatic development and alignment strategic opportunities to exchange best practices, break down silos and accelerate the transformation of patient data into meaningful insights to impact care.”

ASCO says it continues to actively recruit practices of all sizes to join CancerLinQ, which is a wholly owned nonprofit subsidiary of ASCO.

To see which 58 practices have signed on so far, click here.

Dave Pearson

Dave P. has worked in journalism, marketing and public relations for more than 30 years, frequently concentrating on hospitals, healthcare technology and Catholic communications. He has also specialized in fundraising communications, ghostwriting for CEOs of local, national and global charities, nonprofits and foundations.

Around the web

RBMA President Peter Moffatt discusses declining reimbursement rates, recruiting challenges and the role of artificial intelligence in transforming the industry.

Deepak Bhatt, MD, director of the Mount Sinai Fuster Heart Hospital and principal investigator of the TRANSFORM trial, explains an emerging technique for cardiac screening: combining coronary CT angiography with artificial intelligence for plaque analysis to create an approach similar to mammography.

A total of 16 cardiology practices from 12 states settled with the DOJ to resolve allegations they overbilled Medicare for imaging agents used to diagnose cardiovascular disease.